维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Lambers HJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	First morning voids are more reliable than spot urine samples to assess microalbuminuria显示文摘	Witte EC Lambers Heersprink HJ de Zeeuw D	2009	J Am Soc Nephrol2009，20，2：	1
2	Renal and cardio-protective effects of direct renin inhibition: a systematic literature review显示文摘	Lambers Heerspink HJ Perkovic V de Zeeuw D	2009	J Hypertens2009，27，12：	1
3	Rationale for and study design of the sulodexide trials in Type 2 diabetic, hyper- tensive patients with microalbuminuria or overt nephropathy显示文摘	LAMBERS HJ FOWLER M J VOLGI J	2007	Diabetic Med2007，24，：	1
4	Is doubling of serum creatinine a valid clinical ' hard' endpoint in clinical nephrology trials 显示文摘	Lambers Heerspink HJ Perkovic V de Zeeuw D	2011	Nephron Clin Pract2011，119，3：	1
5	First morn- ing voids are more reliable than spot urine samples to assess mi croalbuminuria显示文摘	Witte EC Lambers Heerspink HJ de Zeeuw D	2009	J Am Soc Nephrol2009，20，43：	1
6	First morn- ing voids are more reliable than spot urine samples to assess mi croalbuminuria显示文摘	Witte EC Lambers Heerspink HJ de Zeeuw D	2009	J Am Soe Nephrol2009，20，2：	1
7	Comparison of different measures of urinary protein excretion for prediction of renal events显示文摘	Lambers Heerspink HJ Gansevoort RT Brenner BM		0，，08：	1
8	The selective vitamin D receptor activator for albuminuria lowering (VITAL) study:study design and baseline characteristics显示文摘	Lambers Heerspink HJ Agarwal R Coyne DW	2009	Am J Nephrol2009，30，3：	1
9	Rationale for and study design of the sulodexide trials in type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy显示文摘	Lambers HJ Fowler M J Volgi J	2007	Diabet Med2007，11，24：	1
10	Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes显示文摘	Lambers Heerspink HJ de Zeeuw D Wie L	2013	Diabetes Obes Metab2013，15，9：	1
11	Rationale for and study design of the sulodexide trials in type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephropathy显示文摘	Lambers Heerspink HJ Fowler MJ Volgi J	2007	Diabet Med2007，24，11：	1
12	Rationale for and study design of the sulodexide trials in Type 2 diabetic,hypertensive patients with urinary albumin excretion rate or overt nephropathy显示文摘	Lambers Heerspink HJ Fowler MJ Volgi J	2007	Diabet Med2007，11，24：	1
13	First morning voids are more reliable than spot urine samples to assess microalbuminuria显示文摘	Witte EC Lambers Heerspink HJ de Zeeuw D		0，，：	1
14	Update onmicroalbuminuria as a biomarker in renal and cardiovasculardisease显示文摘	Lambers Heerspink HJ Brinkman JW Bakker SJ	2006	Curr Opin Nephrol Hypertens2006，15，6：	1
15	Al- buminuria assessed from first - morning - void urine samples versus 24 - hour urine collections as a predictor of cardiovascular morbidity and mortality显示文摘	Lambers Heerspink HJ Brantsma AH de Zeeuw D	2008	Am J Epidemiol2008，168，8：	1
16	Comparison of different measures of urinary protein excretion forprediction of renal events显示文摘	Lambers Heerspink HJ Gansevoort RT Brenner BM	2010	J Am Soc Nephrol2010，21，8：	1
17	Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes显示文摘	Lambers Heerspink HJ de Zeeuw D Wie L	2013	Diabetes Obes Metab2013，15，9：	1
18	First morning voids are more reliable than spot urine samples to assess microalbumin uria显示文摘	Witte EC Lambers Heerspink HJ de Zeeuw D	2009	J Am Soc Nephrol2009，20，2：	1
19	Intensities of renal replacement therapy in acute kidney injury:a systematic review and Meta-analysis显示文摘	Jun M Lambers Heerspink HJ Ninomiya T		0，，06：	1
20	First morning voids are more reliable than spot urine samples to assessmicroalbuminuria显示文摘	Witte EC Lambers Heerspink HJ de Zeeuw D		J Am Soc Nephrol0，20，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示